Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|March 1, 2017
An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitorMelanie I Titze, Otmar Schaaf, Marco H Hofmann, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 3, 2021
Novel models for the prediction of drug-gene interactionsDenise Türk, Laura Maria Fuhr, Fatima Zahra Marok, et al.
Thrombosis and Haemostasis|July 1, 2016
Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa studyJacqueline M L Halton, Thorsten Lehr, Lisa Cronin, et al.
Plos One|February 22, 2018
Population nutrikinetics of green tea extractCatharina Scholl, Anna Lepper, Thorsten Lehr, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2017
A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin-integration of in vitro results, Phase I and Phase II data and model application for drug-drug interaction potential analysisNina Hanke, Michael Teifel, Daniel Moj, et al.
Pharmaceutical Research|November 25, 2020
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug InteractionsHannah Britz, Nina Hanke, Mitchell E Taub, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2019
Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and MidazolamHannah Britz, Nina Hanke, Anke-Katrin Volz, et al.
Pharmaceutics|October 27, 2022
Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 PatientsChristiane Dings, Peter Meiser, Frank Holzer, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 24, 2024
Burden of cardiovascular disease attributable to metabolic risks in 204 countries and territories from 1990 to 2021Huimin Chen, Lu Liu, Yi Wang, et al.
Pharmacogenetics and Genomics|August 24, 2011
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapineThorsten Lehr, Jing Yuan, David Hall, et al.
Pageof 13